BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Michael S. Borofsky, Timothy Ito, Andrew B. Rosenkrantz, Samir S. Taneja. Focal therapy for prostate cancer – where are we in 2011?Therapeutic Advances in Urology 2011; 3(4): 183 doi: 10.1177/1756287211418724
Matthias C. Roethke, Michaela Kniess, Sascha Kaufmann, Matthias P. Lichy, Heinz-Peter Schlemmer, Arnulf Stenzl, David Schilling. Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer?World Journal of Urology 2014; 32(2): 379 doi: 10.1007/s00345-013-1106-3
D Gabriele, G Cattari, C Fiorito, M T Carchedi, E Garibaldi. Data collection for models validation: Application to prostate cancer — Clinical aspectsIEEE-EMBS International Conference on Biomedical and Health Informatics (BHI) 2014; : 5 doi: 10.1109/BHI.2014.6864290
Ingrid Mocikova, Jozef Babela, Vladimir Balaz. Prostate cancer - the role of magnetic resonance imagingBiomedical Papers 2012; 156(2): 103 doi: 10.5507/bp.2012.025
Naveen M. Kulkarni, Daniella F. Pinho, Srikala Narayanan, Avinash R. Kambadakone, Jeremy S. Abramson, Dushyant V. Sahani. Imaging for Oncologic Response Assessment in LymphomaAmerican Journal of Roentgenology 2017; 208(1): 18 doi: 10.2214/AJR.16.16180
F. Luyckx, P. Hallouin, C. Barré, G. Aillet, P. Chauveau, J.-F. Hétet, O. Bouchot, J. Rigaud. Cancer de la prostate localisé : l’IRM endorectale à 1,5 Tesla améliore-t-elle la sélection des patients en vue d’une surveillance active ?Progrès en Urologie 2011; 21(2): 114 doi: 10.1016/j.purol.2010.06.010
Gert O. De Meerleer, Piet Ost, Geert M. Villeirs, Nicolaas Lumen, Valérie Fonteyne. Prostate Cancer: A Comprehensive Perspective2013; : 709 doi: 10.1007/978-1-4471-2864-9_60